| Literature DB >> 34556033 |
Mohamed Sabry Abd Elraheam Elsayed1, Samah Mahmoud Eldsouky2, Tamer Roshdy3, Abeer Mohamed Ahmed Bayoume4, Ghada M Nasr5, Ali S A Salama6, Behiry A Akl6, Al Shaimaa Hasan7, Amany Kasem Shahat8, Rana Atef Khashaba9, Walid Abdellatif Abdelhalim9, Hend E Nasr10, Lina Abdelhady Mohammed10, Ahmed Salah3.
Abstract
BACKGROUND: The Shiga toxin-producing Escherichia coli (STEC) represented a great risk to public health. In this study, 60 STEC strains recovered from broiler and duck fecal samples, cow's milk, cattle beef, human urine, and ear discharge were screened for 12 virulence genes, phenotypic and genotypic antimicrobial resistance, and multiple-locus variable-number tandem-repeat analysis (MLVA).Entities:
Keywords: Animals and human; Antimicrobial resistance genes; MLVA genotyping; Shiga toxin-producing Escherichia coli; Virulence genes
Mesh:
Year: 2021 PMID: 34556033 PMCID: PMC8461963 DOI: 10.1186/s12866-021-02308-w
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Types, groups, and prioritization of antimicrobials classified as critically important in human and veterinary medicine
| Antimicrobial agents | Disk concentration | Antimicrobial class | Medical importance | Prioritization criterion |
|---|---|---|---|---|
| Amikacin | 30 μg | Aminoglycosides | High priority critically important | P2 and P3 |
| Amoxicillin/ clavulanic acid | 30 μg | Penicillins | Highest priority critically important | P2 and P3 |
| Ampicillin | 10 μg | Penicillins | Highest priority critically important | P2 and P3 |
| Cephradine | 10 μg | Cephalosporins | Highly important | NA |
| Chloramphenicol | 15 μg | Amphenicols | Highly important | NA |
| Clindamycin | 20 μg | Lincosamides | Highly important | NA |
| Doxycycline | 20 μg | Tetracyclines | Highly important | NA |
| Erythromycin | 20 μg | Macrolides and ketolides | Highest priority critically important | P1, P2 and P3 |
| Nalidixic acid | 30 μg | Quinolones | Highest priority critically important | P1, P2 and P3 |
| Norocillin | 10 μg | Penicillins | High priority critically important | P2 and P3 |
| Oxytetracyclin | 20 μg | Tetracyclines | Highly important | NA |
| Penicillin G | 10 μg | Penicillins | High priority critically important | P2 and P3 |
| Streptomycin | 5 μg | Aminoglycosides | High priority critically important | P2 and P3 |
Primer sequences, anticipated amplicon size, and amplification conditions
| Name | Amplicon | Cycle | Annealing | Primer sequence | Purpose | Reference |
|---|---|---|---|---|---|---|
| 348 | 25 | 56 °C, 60s | F: 5′-CAGTTAATGTGGTGGCGAAGG-3′ R: 5′-CACCAGACAATGTAACCGCTG-3’ | Detect Shiga toxins and their subtypes [ | [ | |
| 498 | 30 | 56 °C, 60s | F:TTTTCACATGTTACCTTTCCT R:CATAGAAGGAAACTCATTAGG | [ | ||
| 192 | 30 | 56 °C, 60s | F:CTTTTCAGTTAATGCGATTGCT R:AACCCCATGATATCGACTGC | |||
| 584 | 25 | 56 °C, 60s | F:ATCCTATTCCCGGGAGTTTACG R:GCGTCATCGTATACACAGGAGC | [ | ||
| 349 | 25 | 65 °C, 40s | F:GCGATACTGRGBACTGTGGCC R:CCGKCAACCTTCACTGTAAATGTG | [ | ||
| 124 | 30 | 65 °C, 40s | F:GCGGTTTTATTTGCATTAGT R:AGTACTCTTTTCCGGCCACT | [ | ||
| 175 | 30 | 65 °C, 40s | F:GGTAAAATTGAGTTCTCTAAGTAT R:CAGCAAATCCTGAACCTGACG | |||
| 267 | 30 | 65 °C, 40s | F:ATGAAGAAGATGTTTATAGCG R:TCAGTTAAACTTCACCTGGGC | |||
| 428 | 30 | 65 °C, 40s | F:AGATTGGGCGTCATTCACTGGTTG R:TACTTTAATGGCCGCCCTGTCTCC | |||
| 573 | 30 | 65 °C, 40s | F:GTTATATTTCTGTGGATATC R:GAATAACCGCTACAGTA | |||
| 682 | 35 | 58 °C, 20s | F:ATTACTGAGATTAAGGCTGAT R:ATTTATTTGCAGCCCCCCAT | Detect intimin [ | [ | |
| 166 | 25 | 56 °C, 60s | F:GTTTATTCTGGGGCAGGCTC R:CTTCACGTCACCATACATAT | Detect enterohemo-lysin [ | [ | |
| 210 | 30 | 58 °C, 60s | F:GCTACATCCTGCTTGCCTTC R:CATAGATCGCCGTGAAGAG | Detect | [ | |
| 659 | 30 | 56 °C, 60s | F:TTGGTTAGGGGCAAGTTTTG R:GTAATGGGCCAATAACACCG | |||
| 418 | 30 | 58 °C, 60s | F:CTTGAGAGCCTTCAACCCAG R:ATGGTCGTCATCTACCTGCC | |||
| 787 | 30 | 60 °C, 60s | F:AAACCATTACGGCATTCTGC R:GACCGGATACACCATCCATC | |||
| 278 | 30 | 58 °C, 60s | F:AAACCACATCCTCCATACGC R:AAATAGGCCACAACCGTCAG | |||
| 468 | 30 | 60 °C, 60s | F:GCTCGGTGGTATCTCTGCTC R:AGCAACAGAATCGGGAACAC | |||
| 280 | 33 | 64 °C, 30s | F: CCTCCCGCACGATGATC R: TCCACGCATCGTCAGGC | Detect class 1 and 2 integrons [ | [ | |
| 300 | 33 | 64 °C, 30s | F: GCAAACGCAAGCATTCATTA R: ACGGATATGCGACAAAAAGG | |||
| 500 | 35 | 55 °C, 1 min | F: TTTGCGATGTGCAGTACCAGTAA R: CTCCGCTGCCGGTTTTATC | Detect extended-spectrum β-lactamase [ | ||
| 415 | 35 | 55 °C, 1 min | F: AAAAATCACTGCGCCAGTTC R: AGCTTATTCATCGCCACGTT | |||
| 800 | 30 | 55 °C, 1 min | T1: CCGTGTCGCCCTTATTCC T2: AGGCACCTATCTCAGCGA | Detect ampicillin-resistance gene [ | ||
| VNTR-3 | (333–334) to (476–477) | 35 | 65 °C, 20s | F:GGCGGTAAGGACAACGGGGTGTTTGAATTG R:GAACAACCTAAAACCCGCCTCGCCATCG | Detect VNTRs in STEC [ | [ |
| VNTR-34 | (170–172) to (313–314) | F:GACAAGGTTCTGGCGTGTTACCAACGG R:GTTACAACTCACCTGCGAATTTTTTAAGTCCC | ||||
| VNTR-9 | (474–475) to (613–614) | GCGCTGGTTTAGCCATCGCCTTCTTCC GTGTCAGGTGAGCTACAGCCCGCTTACGCTC | ||||
| VNTR-25 | (122–124) to (191–192) | GCCGGAGGAGGGTGATGAGCGGTTATATTTAGTG GCGCTG AAAAGACATTCTCTGTTTGGTTTACACGAC | ||||
| VNTR-17 | (135–136) to (247–248) | GCAGTTGCTCGGTTTTAACATTGCAGTGATGA GGAAATGGTTTACATGAGTTTGACGATGGCGATC | ||||
| VNTR-19 | (283–284) to (356–357) | GCAGTGATCATTATTAGCACCGCTTTCTGGATGTTC GGGGCAGGGAATAAGGCCACCTGTTAAGC | ||||
| VNTR-36 | (123–124) to (240–242) | GGCGTCCTTCATCGGCCTGTCCGTTAAAC GCCGCTGAAAGCCCACACCATGC | ||||
| VNTR-37 | (157–158) to (273–274) | GCCGCCCCTTACATTACGCG GACATTC GCAGGAGAACAACAAAACAGACAGTAATCAGAGCAGC |
Results of distribution of the stx1, stx2, and their subtypes gene combinations in STEC strains
| Shiga toxin genes | No. of strains | Percentage |
|---|---|---|
| O146:H21 (1), O1:H7 (1), O127:H6 (1), O78 (4), O91:H21 (3), O2:H6 (5), O128:H2 (1), O86 (1), O17:H18 (3), O7:H2 (3), O8:H21 (5), O121:H7 (1), O55:H7 (1), O75 (1) | 31/60 (51.7%) | |
| O1:H7 (1), O26:H11 (1), O55:H7 (1), O127:H6 (1), O15:H2 (3), O111:H2 (1) | 8/60 (13.3%) | |
| O78 (2), O111:H2 (1), O17:H18 (1), O128:H2 (1) | 5/60 (8.3%) | |
| O153:H2 (1) | 1/60 (1.7%) | |
| O26:H11 (1), O15:H2 (3), O128:H2 (1) | 5/60 (8.3%) | |
| O91:H21(1) | 1/60 (1.7%) | |
| O17:H18 (1), O91:H21(1), O26:H11(1) | 3/60 (5%) | |
| O83 (1), O125:H21(1), O15:H2 (2) | 4/60 (6.7%) | |
| O17:H18 (1) | 1/60 (1.7%) | |
| O124 (1) | 1/60 (1.7%) |
Results of the obtained E. coli strains from different samples
| Strains | Broilers | Duck | Cattle | Human urine | Ear discharge | Total | |
|---|---|---|---|---|---|---|---|
| O146:H21 | 1 | 1/60 (1.6%) | |||||
| O1:H7 | 2 | 2/60 (3.3%) | |||||
| O127:H6 | 1 | 1 | 2/60 (3.3%) | ||||
| O78 | 2 | 4 | 6/60 (10%) | ||||
| O2:H6 | 1 | 2 | 2 | 5/60 (8.3%) | |||
| O91:H21 | 3 | 2 | 5/60 (8.3%) | ||||
| O153:H2 | 1 | 1/60 (1.6%) | |||||
| O128:H2 | 2 | 1 | 3/60 (5%) | ||||
| O26:H11 | 1 | 2 | 3/60 (5%) | ||||
| O121:H7 | 1 | 1/60 (1.6%) | |||||
| O86 | 1 | 1/60 (1.6%) | |||||
| O111:H2 | 2 | 2/60 (3.3%) | |||||
| O55:H7 | 2 | 2/60 (3.3%) | |||||
| O15:H2 | 5 | 3 | 8/60 (13.3%) | ||||
| O17:H18 | 3 | 3 | 6/60 (10%) | ||||
| O7:H2 | 3 | 3/60 (5%) | |||||
| O8:H21 | 2 | 3 | 5/60 (8.3%) | ||||
| O83 | 1 | 1/60 (1.6%) | |||||
| O125:H21 | 1 | 1/60 (1.6%) | |||||
| O75 | 1 | 1/60 (1.6%) | |||||
| O124 | 1 | 1/60 (1.6%) | |||||
| Total | 21 | 60/60 (100%) | |||||
Fig. 1Correlation matrix of phenotypic antimicrobial resistance and antimicrobial resistance genes expressing significant correlations (p < 0.05). White squares are not significantly correlated. Red squares indicated significant positive correlation and blue squares show significant negative correlation. The size and strength of color represent the numerical value of the Pearson correlation coefficient
Results of distribution of virulence genes in STEC isolates from broiler, duck, cattle, and human samples
| Origin | Serotype | Virulence genes | ||||||
|---|---|---|---|---|---|---|---|---|
| Broilers | O146:H21 | +* | + | + | -** | + | – | + |
| Broilers | O1:H7 | + | + | + | – | – | – | + |
| Broilers | O1:H7 | + | + | + | – | + | – | + |
| Broilers | O127:H6 | + | + | + | – | + | – | + |
| Broilers | O78 (2 strains)*** | + | + | + | – | + | – | + |
| Broilers | O2:H6 | + | + | + | – | + | – | – |
| Duck | O91:H21 (2 strains) | + | + | + | – | + | – | + |
| Duck | O78 | + | + | – | – | + | – | + |
| Duck | O153:H2 | + | + | + | + | + | – | – |
| Duck | O91:H21 | + | + | + | – | + | – | – |
| Duck | O2:H6 | + | + | + | – | + | – | – |
| Duck | O128:H2 | + | + | – | – | + | – | – |
| Duck | O78 | + | + | – | – | + | – | – |
| Duck | O2:H6 | + | + | + | – | + | – | + |
| Duck | O78 (2 strains) | + | + | + | – | + | – | + |
| Duck | O26:H11 | + | + | – | – | – | – | + |
| Duck | O128:H2 | + | + | + | – | + | – | + |
| Duck | O121:H7 | + | + | + | – | + | – | – |
| Meat | O86 | + | + | + | – | + | – | + |
| Meat | O111:H2 | + | + | – | – | + | – | + |
| Meat | O111:H2 | + | + | + | – | – | – | – |
| Meat | O128:H2 | + | + | – | – | – | – | – |
| Meat | O26:H11 | + | – | + | – | + | – | + |
| Milk | O55:H7 | + | + | + | – | + | – | – |
| Milk | O26:H11 | + | + | + | – | – | – | + |
| Milk | O55:H7 | + | + | + | – | – | – | + |
| Milk | O91:H21 | + | – | + | + | – | – | – |
| Milk | O91:H21 | + | – | + | – | + | – | + |
| Milk | O127:H6 | + | + | + | – | – | – | + |
| Human urine | O15:H2 | + | + | + | – | – | – | + |
| Human urine | O15:H2 (2 strains) | + | + | – | – | – | – | + |
| Human urine | O15:H2 (2 strains) | + | – | + | – | – | – | + |
| Human urine | O17:H18 | + | + | + | – | + | – | + |
| Human urine | O17:H18 | + | + | – | – | + | – | + |
| Human urine | O17:H18 | + | – | + | – | + | – | + |
| Human urine | O7:H2 (3 strains) | + | + | + | – | + | – | + |
| Human urine | O2:H6 (2 strains) | + | + | + | – | + | – | + |
| Human urine | O8:H21 | + | + | + | – | + | – | + |
| Human urine | O8:H21 | + | + | + | – | + | + | + |
| Human urine | O83 | + | – | + | – | – | – | – |
| Human urine | O125:H21 | + | – | + | – | – | – | + |
| Human urine | O75 | + | + | + | – | + | + | + |
| Human urine | O124 | + | + | – | + | + | – | + |
| Human ear discharge | O8:H21 (3 strains) | + | + | + | – | + | – | + |
| Human ear discharge | O15:H2 (2 strains) | + | + | + | – | – | – | + |
| Human ear discharge | O15:H2 | + | + | – | – | – | – | – |
| Human ear discharge | O17:H18 (2 strains) | + | + | + | – | + | – | + |
| Human ear discharge | O17:H18 | + | – | – | – | + | – | – |
| Total (percentage) | 60/60 (100%) | 51/60 (85%) | 48/60 (80%) | 3/60 (5%) | 42/60 (70%) | 2/60 (3.3%) | 46/60 (76.7%) | |
(+)* positive, (−)** negative
*** Each STEC strain was obtained from separate sample
Fig. 2Heatmap and hierarchical clustering of E. coli isolates to 5 clusters based on their phenotypic (antimicrobial resistance), genotypic (antimicrobial resistance genes), and virulence genes expressing differences between isolates. Red represented presence and blue represented absence of phenotypic resistance, resistance genes, and virulence genes. Hierarchical clustering was performed using Wald’s method and a binary distance matrix
Fig. 3Dendrogram of STEC strains based on their multiple-locus variable-number tandem-repeat analysis (MLVA) profiles. Strains are clustered into two groups, group 1 less complex and included ten types; and group 2 more complex and contained sixteen clustered genotypes